Imipenem alters systemic and liver inflammatory responses in CLP- induced sepsis mice in a dose-dependent manner
Authors:
- 1 April 2021
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 93, 107421
Abstract
No abstract availableKeywords
Funding Information
- Tarbiat Modares University
This publication has 53 references indexed in Scilit:
- Immunodesign of experimental sepsis by cecal ligation and punctureNature Protocols, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Catecholamines induce an inflammatory response in human hepatocytesCritical Care Medicine, 2008
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Cytokine modulation in sepsis and septic shockExpert Opinion on Investigational Drugs, 2002
- What is the role of interleukin 10 in polymicrobial sepsis: Anti-inflammatory agent or immunosuppressant?Surgery, 1999
- Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsisBritish Journal of Surgery, 1994
- Imipenem/CilastatinDrugs, 1992
- Side Effects of Antibiotics on Immune Response Parameters and their Possible Implications in Antimicrobial ChemotherapyZentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology, 1988
- Imipenem/CilastatinDrugs, 1987